Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,135
Closed -$399K 121
2026
Q1
$399K Buy
1,135
+419
+59% +$149K 0.08% 75
2025
Q4
$234K Buy
+716
New +$227K 0.04% 101
2024
Q3
Sell
-668
Closed -$209K 109
2024
Q2
$209K Buy
+668
New +$196K 0.06% 92
2024
Q1
Sell
-1,028
Closed -$296K 104
2023
Q4
$296K Buy
+1,028
New +$280K 0.09% 71

Other funds holding AMGN

Hamilton Wealth's AMGN Position: Q2 2026 in Review

Hamilton Wealth sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,135 shares — an estimated $399K sold.

Hamilton Wealth first reported a position in AMGN in Q4 2023 and held it in 4 quarters. The position peaked at $399K in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hamilton Wealth reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Hamilton Wealth sold 1,135 Amgen shares in Q2 2026, an estimated $399K.
  • Hamilton Wealth first reported a position in Amgen in Q4 2023 and held it in 4 quarters.
  • Hamilton Wealth's Amgen position peaked at $399K in Q1 2026.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.